Delivery Order SPE2DB24D9802-SPE2DB25FJLCC
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Jardiance 25 mg tablets. The order has a potential value of $4,094.64 and is set to be completed by February 9, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that holds an indefinite delivery contract with the Defense Logistics Agency, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,757.54 contract is for the delivery of Jardiance 10mg tablets over a period ending on November 12, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,141.96, is for the delivery of Jardiance 25 mg tablets. This delivery order is placed under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999. This IDC, called the SPE2DB program,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,047.32 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that runs through...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of Jardiance 10 mg tablets. The contract has a potential value of $2,047.32 and a completion date of February 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a comprehensive range of brand and generic prescription and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,275.40 contract is for the delivery of 90 tablets of Jardiance 10 mg, a prescription medication. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,654.30 firm fixed-price contract is for the delivery of Jardiance 25 mg tablets in 90-count packages. The contract has a completion date of July 2, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Jardiance 10 mg tablets. The contract has a potential value of $2,047.32 and a completion date of February 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds a broader Indefinite Delivery Vehicle (IDV) contract, SPE2DB, with the Defense Logistics Agency valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,782.44 contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a prescription medication. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Jardiance 25 mg tablets and has a ceiling value of $18,282.12. It is a firm fixed-price contract with a period of performance ending on May 5, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- SPE2DB24D9802Indefinite Delivery Contract
- SPE2DB24D9802-SPE2DB25FJLCCDelivery Order
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $18,413.70 for 90-count tablets of Jardiance 25 mg on August 18, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. Jardiance is a prescription medication commonly prescribed for type 2 diabetes management, and this delivery supports the Defense Logistics Agency's pharmaceutical supply chain for military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which carries a total contract value of $499,999,999 and remains valid through November 2026. As a substantial pharmaceutical distributor, DMS Pharmaceutical Group has established itself as a critical supplier to federal healthcare systems, leveraging its woman-owned small business status to compete effectively in the federal procurement marketplace while providing comprehensive pharmaceutical products including prescription medications, biologics, and medical consumables to Department of Defense facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.4k | 8/18/25 |